<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04164914</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)420-2018</org_study_id>
    <nct_id>NCT04164914</nct_id>
  </id_info>
  <brief_title>Intestinal Microbiota Adaptation to Prebiotic Administration</brief_title>
  <official_title>Intestinal Microbiota Adaptation to Prebiotic Administration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-absorbable, fermentable residues in the diet increase intestinal gas production and&#xD;
      induce gas-related symptoms, such as flatulence, abdominal bloating and distention; however,&#xD;
      prebiotics, which are also fermented by colonic bacteria, have been shown to improve this&#xD;
      type of symptoms. The aim is to demonstrate whether a prebiotic induces adaptive changes in&#xD;
      metabolic activity of gut microbiota and colonic biomass that explain its beneficial effect&#xD;
      on gas-related symptoms.&#xD;
&#xD;
      Single-centre, single arm, open label, proof-of-concept study in healthy subjects. The study&#xD;
      will consist of a pre-administration phase (2 wk), an administration phase (4 wk) and a&#xD;
      post-administration phase (2 wk). A soluble prebiotic fiber (resistant dextrin 14 g/d) will&#xD;
      be administered during the 4 wk administration phase. During 4 days immediately before, at&#xD;
      the beginning and at the end of the administration phase and at the end of the&#xD;
      post-administration phase participants will be put on a standard diet and the following&#xD;
      outcomes will be measured: a) number of gas evacuations during daytime for 2 days by means of&#xD;
      an event marker; b) volume of gas evacuated via a rectal tube during 4 hours after a test&#xD;
      meal, by means of a barostat; c) microbiota composition by fecal analysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 29, 2019</start_date>
  <completion_date type="Actual">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of daily anal gas evacuations</measure>
    <time_frame>28 days</time_frame>
    <description>Change in the number of anal gas evacuations measured by an event marker from beginning of treatment to end of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of anal gas evacuation</measure>
    <time_frame>28 days</time_frame>
    <description>Change in the volume of anal gas evacuated for 4 hours after a probe meal from beginning of treatment to end of treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiota composition by fecal analysis</measure>
    <time_frame>28 days</time_frame>
    <description>Change from beginning of treatment to end of treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prebiotic administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic</intervention_name>
    <description>Soluble prebiotic fiber (resistant dextrin 14 g/d x 4 weeks)</description>
    <arm_group_label>Healthy subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  gastrointestinal symptoms&#xD;
&#xD;
          -  recent (3 months) antibiotic intake&#xD;
&#xD;
          -  change in dietary habits 4 weeks before&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vall d'Hebron Research Institut</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2019</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intestinal gas</keyword>
  <keyword>healthy subjects</keyword>
  <keyword>microbiota</keyword>
  <keyword>prebiotics</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

